Hershey Announces Fourth-Quarter and Full-Year 2017 Results; Provides 2018 Outlook
Feb 01, 2018 12:00 pm UTC| Business
Fourth-quarter net sales declined 1.6%; full-year net sales increased 1.0%, including the impact of acquisitions and foreign currency exchange rates– Fourth-quarter and full-year foreign currency exchange rates a benefit...
UPS Growth Accelerates In 2017
Feb 01, 2018 12:00 pm UTC| Business
Announces Positive 2018 Outlook Revenue Growth Tops 11% for 4Q17 and 8% for Full-Year 20174Q17 EPS of $1.27; Adjusted 4Q EPS of $1.67 International Export Shipments Rose 16% in 4Q17, Full-Year up 15% Supply Chain ...
Apogee Interactive Celebrates 25 Years Serving the Energy Industry
Feb 01, 2018 12:00 pm UTC| Business
ATLANTA, Feb. 01, 2018 -- As 2018 dawns, Apogee Interactive (AI), Inc. proudly enters its twenty-fifth year of service to the energy utility industry. Part of that pride emanates from Navigant’s conclusion that Apogee...
DropCar Hires Paul Commons as Chief Financial Officer
Feb 01, 2018 12:00 pm UTC| Business
NEW YORK, Feb. 01, 2018 -- DropCar, Inc. (NASDAQ:DCAR) a provider of app-based automotive logistics and concierge services for both consumers and dealers, today announced the appointment of Paul Commons as Chief...
Sandy Spring Bancorp Declares Quarterly Dividend
Feb 01, 2018 12:00 pm UTC| Business
OLNEY, Md., Feb. 01, 2018 -- Sandy Spring Bancorp, Inc., (Nasdaq:SASR), the parent company of Sandy Spring Bank, announced that the board of directors declared a quarterly common stock dividend of $0.26 per share...
Airline Data Platform ATPCO Acquires Rich Content Provider Routehappy
Feb 01, 2018 12:00 pm UTC| Business
DULLES INTERNATIONAL AIRPORT and NEW YORK, Feb. 01, 2018 -- ATPCO, the leading source for airline industry pricing and shopping data, today announced the acquisition of Routehappy, the airline industry’s leading rich...
Nabriva Therapeutics to Present at the Leerink Partners 7th Annual Global Healthcare Conference
Feb 01, 2018 12:00 pm UTC| Business
DUBLIN, Ireland and KING OF PRUSSIA, Pa., Feb. 01, 2018 -- Nabriva Therapeutics plc (NASDAQ:NBRV), a clinical stage biopharmaceutical company engaged in the research and development of novel anti-infective agents to...